Esketamine With or Without Integration Therapy for Treatment-Resistant Depression — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Esketamine With or Without Integration Therapy for Treatment-Resistant Depression — Stella

Recruiting

Back to Treatment-resistant Depression (TRD) trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

Puerto Rico

Pravan Foundation, San Juan

University of Puerto Rico, Department of Psychiatry, San Juan

Key details

Phase

Post-approval study

Sponsor

University of Puerto Rico

Enrollment target

~20 participants

Started

February 2026

Primary completion

December 2026

Age range

21 Years – 65 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov